Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cybulla

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Radiation Research|May 27, 2004
Renal toxicity after radionuclide therapyBieke Lambert, Markus Cybulla, Stefan M Weiner, et al.
Orphanet Journal of Rare Diseases|February 20, 2025
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Orphanet Journal of Rare Diseases|December 28, 2024
Impact of enzyme replacement therapy on clinical manifestations in females with Fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Human Mutation|March 13, 2009
Alu-Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype-phenotype correlations in VHL patientsGerlind Franke, Birke Bausch, Michael M Hoffmann, et al.
Journal of Clinical Medicine|August 26, 2022
Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry DiseaseMarkus Cybulla, Kathleen Nicholls, Sandro Feriozzi, et al.
Molecular Genetics and Metabolism|January 29, 2023
Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter studyJonas Müntze, Kolja Lau, Markus Cybulla, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 30, 2005
Chronic renal failure and proteinuria in adulthood: Fabry disease predominantly affecting the kidneysMarkus Cybulla, Ellen Schaefer, Susanne Wendt, et al.
Journal of Inherited Metabolic Disease|March 4, 2021
Defective lysosomal storage in Fabry disease modifies mitochondrial structure, metabolism and turnover in renal epithelial cellsAnke Schumann, Kristin Schaller, Véronique Belche, et al.
The Keio Journal of Medicine|April 16, 2005
New genetic causes of pheochromocytoma: current concepts and the clinical relevanceHartmut P H Neumann, Markus Cybulla, Hirotaka Shibata, et al.
Journal of the American Society of Nephrology : JASN|June 26, 2001
Effect of ibandronate on bone loss and renal function after kidney transplantationWolfgang Grotz, Christian Nagel, Daria Poeschel, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Radiation Research|May 27, 2004
Renal toxicity after radionuclide therapyBieke Lambert, Markus Cybulla, Stefan M Weiner, et al.
Orphanet Journal of Rare Diseases|February 20, 2025
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Orphanet Journal of Rare Diseases|December 28, 2024
Impact of enzyme replacement therapy on clinical manifestations in females with Fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Human Mutation|March 13, 2009
Alu-Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype-phenotype correlations in VHL patientsGerlind Franke, Birke Bausch, Michael M Hoffmann, et al.
Journal of Clinical Medicine|August 26, 2022
Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry DiseaseMarkus Cybulla, Kathleen Nicholls, Sandro Feriozzi, et al.
Molecular Genetics and Metabolism|January 29, 2023
Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter studyJonas Müntze, Kolja Lau, Markus Cybulla, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 30, 2005
Chronic renal failure and proteinuria in adulthood: Fabry disease predominantly affecting the kidneysMarkus Cybulla, Ellen Schaefer, Susanne Wendt, et al.
Journal of Inherited Metabolic Disease|March 4, 2021
Defective lysosomal storage in Fabry disease modifies mitochondrial structure, metabolism and turnover in renal epithelial cellsAnke Schumann, Kristin Schaller, Véronique Belche, et al.
The Keio Journal of Medicine|April 16, 2005
New genetic causes of pheochromocytoma: current concepts and the clinical relevanceHartmut P H Neumann, Markus Cybulla, Hirotaka Shibata, et al.
Journal of the American Society of Nephrology : JASN|June 26, 2001
Effect of ibandronate on bone loss and renal function after kidney transplantationWolfgang Grotz, Christian Nagel, Daria Poeschel, et al.
Pageof 3